Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)

10.08
BATS BZX Real-Time Price
As of 2:01pm ET
 -0.11 / -1.08%
Today’s Change
8.07
Today|||52-Week Range
18.00
-27.11%
Year-to-Date
No recent news for Lexicon Pharmaceuticals Inc.

Today’s Trading

Previous close10.19
Today’s open10.14
Day’s range9.97 - 10.27
Volume16,494
Average volume (3 months)797,335
Market cap$1.1B
Data as of 2:01pm ET, 12/18/2017

Growth & Valuation

Earnings growth (last year)-2,620.00%
Earnings growth (this year)+0.46%
Earnings growth (next 5 years)+30.87%
Revenue growth (last year)-35.90%
P/E ratioNM
Price/Sales17.24
Price/Book6.75

Competitors

 Today’s
change
Today’s
% change
EBSEmergent BioSolution...-0.57-1.22%
PCRXPacira Pharmaceutica...-1.90-4.33%
INVAInnoviva Inc+0.26+1.94%
MYOKMyoKardia Inc-0.05-0.13%
Data as of 2:02pm ET, 12/18/2017

Financials

Next reporting dateMarch 2, 2018
EPS forecast (this quarter)-$0.43
Annual revenue (last year)$83.3M
Annual profit (last year)-$141.4M
Net profit margin-169.71%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Lonnel Coats
CFO, EVP-Corporate &
Administrative Affairs
Jeffrey L. Wade
Corporate headquarters
The Woodlands, Texas

Forecasts